Q2BI offers the expertise and experience to deliver innovative therapeutics to the market. Our preclinical, clinical, biostatistics and regulatory consultants bring a broad range of knowledge and in-depth understanding of global and local market landscape and regulatory guidelines. Our team creates tailored development strategies to meet the individual needs, from early phase to late-stage development.
We have deep experience in development of pharmaceutical products in rare diseases and pediatric indications.
Q2BI Drug Safety case management utilizes fully E2B (R3) compliant databases and touches on all phases of your products life cycle from clinical development through post-marketing activities. You will have peace of mind as your product evolves from cradle to retirement (death).